Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Masao Honda
Post-Progression Survival and Progression-Free Survival in Patients With Advanced Hepatocellular Carcinoma Treated by Sorafenib
Hepatology Research
Hepatology
Infectious Diseases
Enhanced Antitumor Effects of a Bicistronic Adenovirus Vector Expressing Both Herpes Simplex Virus Thymidine Kinase and Monocyte Chemoattractant Protein-1 Against Hepatocellular Carcinoma
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
‹
1
2
Related publications
Early Α-Fetoprotein Response Predicts Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib
Journal of Hepatocellular Carcinoma
Impact of Adverse Events on the Progression-Free Survival of Patients With Advanced Hepatocellular Carcinoma Treated With Lenvatinib: A Multicenter Retrospective Study
Drugs - Real World Outcomes
Pharmacology
Long Duration of Stable Disease May Improve Overall Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib
Acta Hepatologica Japonica
Hepatology
Development and Validation of a Prognostic Nomogram for Progression-Free Survival in Patients With Advanced Renal Cell Carcinoma Treated With Pazopanib
Oncology
Medicine
Cancer Research
Oncology
Association of MDM2 Expression With Shorter Progression-Free Survival and Overall Survival in Patients With Advanced Pancreatic Cancer Treated With Gemcitabine-Based Chemotherapy
PLoS ONE
Multidisciplinary
Advanced Hepatocellular Carcinoma: Pretreatment Contrast-Enhanced CT Texture Parameters as Predictive Biomarkers of Survival in Patients Treated With Sorafenib
Radiology
Nuclear Medicine
Radiology
Imaging
EIF4EBP1 Overexpression Is Associated With Poor Survival and Disease Progression in Patients With Hepatocellular Carcinoma
PLoS ONE
Multidisciplinary
Attenuation of Liver Stiffness in Sorafenib-Treated Patients With Advanced Hepatocellular Carcinoma
Hepatoma Research
Therapeutic Effect of Apatinib on Overall Survival Is Mediated by Prolonged Progression-Free Survival in Advanced Gastric Cancer Patients
Oncotarget
Oncology
